Up-regulation of HOXA13 in esophageal squamous cell carcinoma of stage IIa and its effect on the prognosis / 中华胃肠外科杂志
Chinese Journal of Gastrointestinal Surgery
;
(12): 20-23, 2009.
Artículo
en Chino
| WPRIM
| ID: wpr-326566
ABSTRACT
<p><b>OBJECTIVE</b>To investigate the expression of HOXA13 gene in stage-II(a esophageal squamous cell carcinoma(ESCC), and to evaluate its relationship with clinicopathological characteristics and prognosis.</p><p><b>METHODS</b>The expression of HOXA13 was examined by immunohistochemistry(IHC) in specimens from 39 patients with ESCC of stage-II(a, who underwent resection from 1995 to 2002. SPSS software was used to analyze the relationship between HOXA13 expression and clinicopathological characteristics and prognosis of patients.</p><p><b>RESULTS</b>The expression of HOXA13 protein was detected in ESCC tissue, and the positive rate was 61.5%. The median survival time of patients without HOXA13 expression(>72 months) was significantly longer than those with HOXA13 expression (24 months)( P=0.023). Multivariate analysis showed that HOXA13 expression was independent predictor of disease-free survival time of patients with ESCC.</p><p><b>CONCLUSION</b>The expression of HOXA13 can be detected in ESCC and is a negative independent predictor of disease-free survival, which implies that HOXA13 might play a role in ESSC, and may be used as a clinical tumor marker of ESCC.</p>
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Patología
/
Pronóstico
/
Neoplasias Esofágicas
/
Carcinoma de Células Escamosas
/
Proteínas de Homeodominio
/
Metabolismo
/
Estadificación de Neoplasias
Tipo de estudio:
Estudio pronóstico
Límite:
Femenino
/
Humanos
/
Masculino
Idioma:
Chino
Revista:
Chinese Journal of Gastrointestinal Surgery
Año:
2009
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS